NasdaqGS - Delayed Quote • USD
Acadia Healthcare Company, Inc. (ACHC)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 4:06 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 10 | 11 | 11 | 11 |
Avg. Estimate | 0.81 | 0.95 | 3.54 | 4.03 |
Low Estimate | 0.78 | 0.86 | 3.21 | 3.8 |
High Estimate | 0.84 | 1.01 | 3.65 | 4.26 |
Year Ago EPS | 0.75 | 0.92 | 3.44 | 3.54 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 11 | 11 | 11 | 11 |
Avg. Estimate | 779.17M | 802.15M | 3.22B | 3.54B |
Low Estimate | 767.2M | 788M | 3.2B | 3.49B |
High Estimate | 782.08M | 816.67M | 3.26B | 3.68B |
Year Ago Sales | 704.27M | -- | 2.93B | 3.22B |
Sales Growth (year/est) | 10.60% | -- | 10.00% | 9.90% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 0.71 | 0.86 | 0.89 | 0.79 |
EPS Actual | 0.75 | 0.92 | 0.91 | 0.85 |
Difference | 0.04 | 0.06 | 0.02 | 0.06 |
Surprise % | 5.60% | 7.00% | 2.20% | 7.60% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.81 | 0.95 | 3.54 | 4.03 |
7 Days Ago | 0.8 | 0.95 | 3.54 | 4.03 |
30 Days Ago | 0.8 | 0.95 | 3.54 | 4.03 |
60 Days Ago | 0.81 | 1 | 3.7 | 4.12 |
90 Days Ago | 0.81 | 1 | 3.72 | 4.14 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | 1 | 1 | -- | 1 |
Growth Estimates
CURRENCY IN USD | ACHC | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 8.00% | -- | -- | 1.60% |
Next Qtr. | 3.30% | -- | -- | 10.50% |
Current Year | 2.90% | -- | -- | 5.20% |
Next Year | 13.80% | -- | -- | 13.30% |
Next 5 Years (per annum) | 10.12% | -- | -- | 11.22% |
Past 5 Years (per annum) | 16.39% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
Earnings
Upgrades & Downgrades
Maintains | Mizuho: Neutral to Neutral | 3/6/2024 |
Initiated | Barclays: Overweight | 3/6/2024 |
Reiterates | Cantor Fitzgerald: Neutral to Neutral | 3/5/2024 |
Reiterates | RBC Capital: Outperform to Outperform | 3/4/2024 |
Maintains | TD Cowen: Outperform to Outperform | 3/1/2024 |
Maintains | UBS: Buy to Buy | 2/28/2024 |
Related Tickers
EHC Encompass Health Corporation
79.22
+0.76%
USPH U.S. Physical Therapy, Inc.
99.09
+1.64%
SGRY Surgery Partners, Inc.
23.83
+1.75%
CHE Chemed Corporation
600.41
+0.50%
UHS Universal Health Services, Inc.
157.47
+2.49%
AIRS AirSculpt Technologies, Inc.
5.70
+4.78%
ENSG The Ensign Group, Inc.
118.26
+1.53%
ADUS Addus HomeCare Corporation
97.19
+0.03%
FMS Fresenius Medical Care AG
19.54
+0.77%
THC Tenet Healthcare Corporation
93.19
+2.32%